Background-Edward W. Thwaite

Edward W. Thwaite - President of E.W. Thwaite Associates, Inc. - brings to clients extensive professional experience in both the brand and generic pharmaceutical industries. During his 17 years at Hoffmann-La Roche, Ed managed virtually every product in the company's pharmaceutical line, including the launches of Accutane® and Zantac® (in a groundbreaking joint marketing arrangement with Glaxo). Ed also managed the extensive work undertaken with regard to the patent expirations of and impending generic competition for Dalmane® and Valium®.

His experiences with Dalmane and Valium provided Ed with valuable exposure to the future of the generic pharmaceutical business. In 1985, at the most opportune time for the generic industry (due to passage of the Hatch-Waxman Act; Public Law 98-417), Ed joined Zenith Laboratories as Vice President of Marketing and Sales. During his years at Zenith, Ed coordinated the sales and marketing of more than 100 products, as well as having managing capacities for customer service, regulatory administration, and the launches of 12 products.

E.W. Thwaite Associates, Inc., is a unique consulting firm. With his years as an integral part of both the branded and generic pharmaceutical industries, Ed delivers a special vision of the distinct industries as well as the pharmaceutical industry as a whole. In addition, he also brings the following to clients:

• Management experience in establishing policy and working on the front lines to implement policy
• Extensive experience in marketing and sales, and directing operations and regulatory issues
• An unparalleled view of the two distinct businesses - brands and generics, thereby allowing macroperspective and detailed views of these sectors.
• As needed, the firm employs various experts - in finance, operations, manufacturing, legal, regulatory, and creative - all of whom provide practical knowledge and experience in the generic pharmaceutical business

In addition, Mr. Thwaite has written significant articles on brand/generic issues.

• Beat the Generics by Joining Them - Medical Marketing & Media
• Brand Name and Generic Companies Jockey for Off-Patent Business Position - Medical Marketing & Media
• Brands and Generics - Which Way to Turn? - Product Management Today
• Generic Drug Advertising Dollars and Trade Journals - Product Management Today
• Managed Care & Generic...A Marriage Made in Heaven? - Medical Marketing & Media
• Pharmaceutical Product Life Cycles: The End of One and the Start of Another - Product Management Today
• Trends in Generic Advertising - Medical Marketing & Media